Researchers
Discover all researchers in life sciences
Loading researchers...
Discover all researchers in life sciences
Associate Professor at Pharmaceutics and Pharmaceutical Technology
Ask questions about Hashem O. Alsaab's research, publications, and ongoing work
Explored the use of dendrimer nanoarchitectures for improved cancer diagnosis and targeted anticancer drug delivery, contributing to advancements in personalized medicine.
Detailed the history and development of PLGA-based nanomedicine, highlighting its clinical applications in treating various diseases.
Investigated the potential of nanomaterials in antiangiogenic therapies for cancer, emphasizing their role in personalized medicine approaches.
Focused on improving the therapeutic efficiency of noncoding RNAs in cancer treatment through targeted drug delivery systems.
Reviewed the application of phage display-derived monoclonal antibodies from bench to bedside, highlighting their therapeutic potential.
Explored the use of CD44 targeted nanomaterials for the treatment of triple-negative breast cancer, a particularly aggressive form of the disease.
Investigated the pathological role of long non-coding RNAs (lncRNAs) in regulating the Wnt/β-catenin signaling pathway during epithelial-mesenchymal transition (EMT).
Hashem O. Alsaab is an Associate Professor specializing in pharmaceutics and pharmaceutical technology, with a focus on nanomedicine, drug delivery systems, and molecular mechanisms in cancer. His research aims to improve therapeutic efficacy and diagnostic precision through innovative nanoplatforms and targeted drug delivery.
Researchers with overlapping expertise and complementary work
Finding similar researchers...